Immuneering Corporation
IMRX
$5.02
$0.173.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.30% | -16.24% | 22.62% | -3.68% | 4.07% |
| Total Depreciation and Amortization | 3.49% | 6.61% | -3.48% | -6.10% | -0.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.64% | -15.88% | 1.96% | -4.14% | -9.32% |
| Change in Net Operating Assets | 92.70% | -7,830.02% | -93.92% | -58.67% | 464.08% |
| Cash from Operations | 10.48% | -87.32% | 17.84% | -26.80% | 32.91% |
| Capital Expenditure | 65.71% | 35.51% | -1,597.26% | -247.62% | 76.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.68% | 28.90% | -- | -- | -- |
| Cash from Investing | 116.62% | 28.91% | -1,215,241.10% | -247.62% | 76.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.39% | -57.93% | -99.80% | 10,298,328.57% | -99.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 74.39% | -4,704.53% | -- |
| Cash from Financing | -86.39% | 150.57% | -100.17% | 343,958.23% | -100.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.63% | 17.79% | -149.16% | 2,215.70% | -3,308.67% |